In this podcast, expert cardiology pharmacists Dr Kathleen Lusk and Dr Stephanie Dwyer Kaluzna discuss the prevalence, burden, and consequences of undiagnosed NVAF. They will explore evidence-based methods for NVAF screening and provide strategies to incorporate these within various pharmacy settings.
This podcast is the first in a series of three featuring cardiology pharmacists Kathleen A. Lusk, PharmD, BCPS, BCCP, and Stephanie Dwyer Kaluzna, PharmD, BCCP. In this episode, Drs Lusk and Dwyer Kaluzna provide an overview of nonvalvular atrial fibrillation (NVAF), including prevalence, burden, and consequences of undiagnosed NVAF and the role of pharmacists in screening for the condition in various pharmacy settings.
Presenters:
Kathleen A. Lusk, PharmD, BCPS, BCCP
Associate Professor and Vice Chair
Department of Pharmacy Practice
University of the Incarnate Word Feik School of Pharmacy
Adjunct Assistant Professor
Clinical Pharmacy Specialist
Division of Cardiology
Department of Medicine
UT Health San Antonio
San Antonio, Texas
Stephanie Dwyer Kaluzna, PharmD, BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
University of Illinois Chicago College of Pharmacy
Cardiovascular Clinical Pharmacist
University of Illinois Hospital and Health Science System
Chicago, Illinois
Content is based on an online CE program supported by an educational grant from the Bristol Myers Squibb Pfizer Alliance.
This podcast series was first delivered as live webinars, which are now available as on-demand, CE-certified microlearning modules with downloadable slidesets. The program also features a ClinicalThought commentary and a downloadable infographic reference guide. To access the full program, go to
https://bit.ly/3OMazV8